IP Library › Granted Patent US 12,575,563
Granted Patent B2
US 12,575,563 · App. 18/642,653 · Granted Mar 17, 2026

Surfactants for agricultural products

Inventor: Edward Asirvatham (Chatham, NJ)
Assignee: AdvanSix Resins & Chemicals LLC
A01N25/30A01N37/44A01N41/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,575,563
App. No.
18/642,653
Granted
Mar 17, 2026
Kind
B2
Abstract

Agricultural products, such as pesticides, plant growth regulators, fungicides, herbicides, and insecticides, may be formulated to include one or more surfactants, from one or more surfactant classes, such as derivatives of amino acids that have surface-active properties.

Claims (50)

1 . A formulation for a pesticide, comprising:

at least one surfactant of Formula I,

wherein R 1 and R 2 may be the same or different, and may be selected from the group consisting of hydrogen and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

n is an integer from 2 to 5 (including 2 and 5);

m is an integer from 9 to 20 (including 9 and 20);

the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

an optional counterion associated with the compound which, if present, is hydroxide; and

a pesticide.

2 . The formulation of claim 1 , further comprising a water-insoluble solvent.

3 . The formulation of claim 1 , wherein the surfactant comprises at least one of

dodecyl 6-(dimethylamino)hexanoate N-oxide, having the following formula:

4-((6-(dodecyloxy)-6-oxohexyl)dimethylammonio)butane-1-sulfonate, having the following formula:

 and combinations thereof.

4 . The formulation of claim 1 , wherein the pesticide is an insecticide.

5 . The formulation of claim 4 , further comprising an antifoaming agent.

6 . The formulation of claim 4 , further comprising an antifreezing agent.

7 . The formulation of claim 4 , further comprising water.

8 . The formulation of claim 4 , wherein the surfactant comprises at least one of

dodecyl 6-(dimethylamino)hexanoate N-oxide, having the following formula:

4-((6-(dodecyloxy)-6-oxohexyl)dimethylammonio)butane-1-sulfonate, having the following formula:

 and combinations thereof.

9 . A formulation for a fungicide, comprising:

at least one surfactant of Formula I,

wherein R 1 and R 2 may be the same or different, and may be selected from the group consisting of hydrogen and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

n is an integer from 2 to 5 (including 2 and 5);

m is an integer from 9 to 20 (including 9 and 20);

the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

an optional counterion associated with the compound which, if present, is hydroxide; and

a fungicide.

10 . The formulation of claim 9 , further comprising a co-surfactant.

11 . The formulation of claim 9 , further comprising a carrier agent.

12 . The formulation of claim 9 , wherein the surfactant comprises at least one of

dodecyl 6-(dimethylamino)hexanoate N-oxide, having the following formula:

4-((6-(dodecyloxy)-6-oxohexyl)dimethylammonio)butane-1-sulfonate, having the following formula:

 and combinations thereof.

13 . A formulation for an herbicide, comprising:

at least one surfactant of Formula I,

wherein R 1 and R 2 may be the same or different, and may be selected from the group consisting of hydrogen and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

n is an integer from 2 to 5 (including 2 and 5);

m is an integer from 9 to 20 (including 9 and 20);

the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl, wherein the C 1 -C 6 alkyl may optionally be substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

an optional counterion associated with the compound which, if present, is hydroxide; and

an herbicide.

14 . The formulation of claim 13 , further comprising a second herbicide.

15 . The formulation of claim 13 , further comprising a water-insoluble solvent.

16 . The formulation of claim 13 , further comprising water.

17 . The formulation of claim 13 , wherein the surfactant comprises at least one of

dodecyl 6-(dimethylamino)hexanoate N-oxide, having the following formula:

4-((6-(dodecyloxy)-6-oxohexyl)dimethylammonio)butane-1-sulfonate, having the following formula:

 and combinations thereof.

Assignments (1)
SECURITY INTEREST Recorded Aug 14, 2026
From: ADVANSIX INC.; ADVANSIX RESINS & CHEMICALS LLC
To: CITIZENS BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 076163/0178 →
Continuity (3)
Division 17196874 · Mar 9, 2021
Provisional Application 62988203 · Mar 11, 2020
Related Publication 20240315239A1 · Sep 26, 2024
References Cited (132)
US 3213500A · Thompson · 1965 [cited by applicant]
US 3704486A · Blacklock · 1972 [cited by applicant]
US 4276460A · Haesly et al. · 1981 [cited by applicant]
US 4297769A · Coules · 1981 [cited by applicant]
US 4502193A · Harmon et al. · 1985 [cited by applicant]
US 4664458A · Worth · 1987 [cited by applicant]
US 5060100A · Mihara et al. · 1991 [cited by applicant]
US 5580203A · Read et al. · 1996 [cited by applicant]
US 5706559A · Oliver et al. · 1998 [cited by applicant]
US 5798095A · Racky · 1998 [cited by applicant]
US 5834006A · Smith et al. · 1998 [cited by applicant]
US 5958894A · Heath et al. · 1999 [cited by applicant]
US 5972323A · Lang et al. · 1999 [cited by applicant]
US 6114757A · Delprete · 2000 [cited by applicant]
US 6304986B1 · Ma et al. · 2001 [cited by applicant]
US 6414028B1 · Bueyuektimkin et al. · 2002 [cited by applicant]
US 6501030B1 · Parizi et al. · 2002 [cited by applicant]
US 6702592B1 · Harden et al. · 2004 [cited by applicant]
US 7646556B1 · Kose et al. · 2010 [cited by applicant]
US 7653847B1 · Liikanen et al. · 2010 [cited by applicant]
US 7768736B2 · Belmont et al. · 2010 [cited by applicant]
US 8599507B2 · Sanvido et al. · 2013 [cited by applicant]
US 8964320B1 · Hu et al. · 2015 [cited by applicant]
US 9142246B1 · Trantham et al. · 2015 [cited by applicant]
US 9484059B2 · Lim et al. · 2016 [cited by applicant]
US 9552846B1 · Lim · 2017 [cited by applicant]
US 20010031703A1 · Ueda · 2001 [cited by applicant]
US 20030081357A1 · Hong et al. · 2003 [cited by applicant]
US 20080259100A1 · Rengaswamy et al. · 2008 [cited by applicant]
US 20090156812A1 · MacDougall et al. · 2009 [cited by applicant]
US 20120040834A1 · Blease et al. · 2012 [cited by applicant]
US 20130336903A1 · Fernandez et al. · 2013 [cited by applicant]
US 20170079898A1 · Fevola et al. · 2017 [cited by applicant]
US 20190314524A1 · Ansell et al. · 2019 [cited by applicant]
US 20210229053A1 · Asirvatham et al. · 2021 [cited by applicant]
US 20210230100A1 · Asirvatham et al. · 2021 [cited by applicant]
US 20210230106A1 · Asirvatham et al. · 2021 [cited by applicant]
US 20210230107A1 · Asirvatham et al. · 2021 [cited by applicant]
US 20210230108A1 · Asirvatham et al. · 2021 [cited by applicant]
US 20210283030A1 · Asirvatham · 2021 [cited by applicant]
US 20210284896A1 · Asirvatham · 2021 [cited by applicant]
US 20210284936A1 · Asirvatham · 2021 [cited by applicant]
US 20210289776A1 · Asirvatham · 2021 [cited by applicant]
US 20210290765A1 · Asirvatham · 2021 [cited by applicant]
US 20210292583A1 · Asirvatham · 2021 [cited by applicant]
US 20210292647A1 · Asirvatham · 2021 [cited by applicant]
US 20220177551A1 · Hazen et al. · 2022 [cited by applicant]
US 20220307017A1 · Pascolo · 2022 [cited by applicant]
US 20220332722A1 · Mulvihill et al. · 2022 [cited by applicant]
US 20230009765A1 · Chung et al. · 2023 [cited by applicant]
US 20250134978A1 · Valiante et al. · 2025 [cited by applicant]
US 20250250451A1 · Asirvatham · 2025 [cited by applicant]
US 20250257029A1 · Asirvatham et al. · 2025 [cited by applicant]
AU 2003245683A1 · 2003 [cited by applicant]
CN 105802600A · 2016 [cited by applicant]
CN 108024935A · 2018 [cited by applicant]
DE 3939746A1 · 1991 [cited by applicant]
DE 29622184U1 · 1997 [cited by applicant]
EP 0638236A1 · 1995 [cited by applicant]
EP 0826661A2 · 1998 [cited by applicant]
GB 0934965A · 1963 [cited by applicant]
GB 2204740A · 1988 [cited by applicant]
GB 2311033A · 1997 [cited by applicant]
JP 49082624A · 1974 [cited by applicant]
JP 61278341A · 1986 [cited by applicant]
JP 04183864A · 1992 [cited by applicant]
JP 04349284A · 1992 [cited by applicant]
JP 07223912A · 1995 [cited by applicant]
JP 08007556A · 1996 [cited by applicant]
JP 08092875A · 1996 [cited by applicant]
JP 08231478A · 1996 [cited by applicant]
JP 09266021A · 1997 [cited by applicant]
JP 11233910A · 1999 [cited by applicant]
JP 2001122837A · 2001 [cited by applicant]
JP 2002226900A · 2002 [cited by applicant]
JP 2004514646A · 2004 [cited by applicant]
JP 2006294170A · 2006 [cited by applicant]
JP 4183864B2 · 2008 [cited by applicant]
JP 4982624B1 · 2012 [cited by applicant]
JP 2017195029A · 2017 [cited by applicant]
JP 2018533573A · 2018 [cited by applicant]
JP 2020506189A · 2020 [cited by applicant]
JP 2022546410A · 2022 [cited by applicant]
JP 2022546412A · 2022 [cited by applicant]
JP 2022546417A · 2022 [cited by applicant]
JP 2022546418A · 2022 [cited by applicant]
JP 2023517666A · 2023 [cited by applicant]
KR 1020120026488A · 2012 [cited by applicant]
WO 8903176A1 · 1989 [cited by applicant]
WO 9616930A1 · 1996 [cited by applicant]
WO 9845233A2 · 1998 [cited by applicant]
WO 0368377A1 · 2003 [cited by applicant]
WO 2012049159A1 · 2012 [cited by applicant]
WO 2012061093A1 · 2012 [cited by applicant]
WO 2017012087A1 · 2017 [cited by applicant]
WO 2017021271A1 · 2017 [cited by applicant]
WO 2017048555A1 · 2017 [cited by applicant]
WO 2017079898A1 · 2017 [cited by applicant]
WO 2017081277A1 · 2017 [cited by applicant]
WO 2017199921A1 · 2017 [cited by applicant]
WO 2018115191A1 · 2018 [cited by applicant]
WO 2021154582A1 · 2021 [cited by applicant]
WO 2021154583A1 · 2021 [cited by applicant]
WO 2021154584A1 · 2021 [cited by applicant]
WO 2021154585A1 · 2021 [cited by applicant]
WO 2021154587A1 · 2021 [cited by applicant]
Focus Technology Company, Daily Chemical Grade Antifreeze Thickener Hydroxypropyl Methylcellulose HPMC, Accessed 2023, pp. 1-5. (Year: 2023). [cited by applicant]
Hrabálek et al., “Esters of omega-amino acids as flexible penetration enhancers”, Pharmazie, vol. 49, No. 5, May 1994, pp. 325-328. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/014440, mailed on Apr. 30, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/014444, mailed on Apr. 26, 2021, 12 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/014445, mailed on Apr. 26, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/014447, mailed on Apr. 30, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/014457, mailed on Apr. 30, 2021, 8 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/021565, mailed on Jun. 18, 2021, 13 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/021569, mailed on May 17, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/21571, mailed on Jul. 9, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/21574, mailed on Jul. 1, 2021, 10 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/21595, mailed on Jul. 30, 2021, 15 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/21596, mailed on Jun. 22, 2021, 10 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/21597, mailed on Aug. 9, 2021, 11 pages. [cited by applicant]
Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US21/21595, mailed on Jun. 9, 2021, 9 pages. [cited by applicant]
Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US21/21597, mailed on Jun. 17, 2021, 7 pages. [cited by applicant]
Kerry P. Mahon et al: “Combinatorial Approach to Determine Functional Group Effects on Lipidoid-Mediated si RNA Delivery”, Bioconjugate Chemistry, vol. 21, No. 8, Aug. 18, 2010 (Aug. 18, 2020), pp. 1448-1454. [cited by applicant]
Novotný et al., “Transkarbams as transdermal permeation enhancers: Effects of ester position and ammonium carbamate formation”, Bioorganic & Medicinal Chemistry Letters, vol. 20, No. 09, May 1, 2010, pp. 2726-2728. [cited by applicant]
Yasa, S.R., et al., “Synthesis, characterization, antimicrobial and biofilm inhibitory activities of new N-oxide esters,” Medicinal Chemistry Research, vol. 26, No. 8, Apr. 3, 2017, pp. 1689-1696. [cited by applicant]
Berge et al. Pharmaceutical Salts. Journal of Pharmaceutical Sciences 66(1): 1-19 (Jan. 1977). [cited by applicant]
Dragicevic, N. et al. < u> Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. < /u> NewYork, Springer, 2015. (Year: 2015). [cited by applicant]
Moulik (Current Science, 1996, vol. 71, No. 5, 368). (Year: 1996). [cited by applicant]
Search Report and Written Opinion received for Singapore Patent Application No. SG 11202251383Q, mailed on May 1, 2025, 7 pages. [cited by applicant]
Skokina et al., “Protective Properties of Surfactants Based on Dimethylaminoethanol”, Protection of Metals, vol. 39, No. 3, May 2003, pp. 288-290. [cited by applicant]
Som, Journal of Pharmacy and Bioallied Sciences, vol. 4, Iss. 1, 2012 (Year: 2012). [cited by applicant]
Yamauchi et al., “Surfactants in the pharmaceutical field”, OleoScience, vol. 2, No. 11, 2002, pp. 697-704. [cited by applicant]